Sohn, S.-H.; Sul, H.J.; Kim, B.J.; Zang, D.Y.
Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the MET Gene: Doublet Treatment versus Single Agent Treatment. Int. J. Mol. Sci. 2024, 25, 1769.
https://doi.org/10.3390/ijms25031769
AMA Style
Sohn S-H, Sul HJ, Kim BJ, Zang DY.
Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the MET Gene: Doublet Treatment versus Single Agent Treatment. International Journal of Molecular Sciences. 2024; 25(3):1769.
https://doi.org/10.3390/ijms25031769
Chicago/Turabian Style
Sohn, Sung-Hwa, Hee Jung Sul, Bum Jun Kim, and Dae Young Zang.
2024. "Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the MET Gene: Doublet Treatment versus Single Agent Treatment" International Journal of Molecular Sciences 25, no. 3: 1769.
https://doi.org/10.3390/ijms25031769
APA Style
Sohn, S.-H., Sul, H. J., Kim, B. J., & Zang, D. Y.
(2024). Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the MET Gene: Doublet Treatment versus Single Agent Treatment. International Journal of Molecular Sciences, 25(3), 1769.
https://doi.org/10.3390/ijms25031769